Skip to main content

Table 3 Stratification of prognostic factors by HBV status

From: Prognosis of the intrahepatic cholangiocarcinoma after resection: hepatitis B virus infection and adjuvant chemotherapy are favorable prognosis factors

Clinical factor Chronic hepatitis P value All makers negative P value The anti-HBs positive
Total 37   23   21
Age   0.051   0.690  
   ≤ 60 y 24 (67.2%)   9 (39.1%)   7 (29.2%)
   > 60 y 13 (32.8%)   14 (60.9%)   14 (70.8%)
CA19-9   0.047   0.622  
   ≤ 200 U/ml 21 (56.8%)   7 (30.4%)   5 (23.8%)
   > 200 U/ml 16 (43.2%)   16 (69.6%)   16 (76.2%)
TIBL   0.051   0.131  
   ≤ 20 μmol/L 24 (64.9%)   9 (39.1%)   13 (61.9%)
   > 20 μmol/L 13 (35.1%)   14 (60.9%)   8 (38.1%)
GGT   0.496   0.870  
   ≤ 64 U/L 11 (29.7%)   5 (21.7%)   5 (23.8%)
   > 64 U/L 26 (70.3%)   18 (78.3%)   16 (76.2%)
ALP   0.001   0.202  
   ≤ 119 U/L 16 (43.2%)   3 (13.0%)   6 (28.6%)
   > 119 U/L 11 (56.8%)   20 (87.0%)   15 (71.4%)
Lymphatic metastasis   0.001   0.862  
   No 20 (54.0%)   6 (26.8%)   5 (23.8%)
   Yes 17 (46.0%)   17 (73.2%)   16 (76.2%)
Operation pattern   0.518   0.717  
   Radical 24 (64.9%)   13 (56.5%)   13 (61.9%)
   Palliative 13 (35.1%)   10 (43.5%)   8 (38.1%)
Intrahepatic metastasis   0.811   0.820  
   No 23 (62.1%)   15 (65.2%)   13 (61.9%)
   Yes 14 (37.9%)   8 (34.8%)   8 (38.1%)
Adjuvant chemotherapy 8 (21.6%)   5 (21.7%)   5 (23.8%)